Clinical trial
Study to Investigate the Initial Stages of Enamel Erosion in Vivo
NCT02533466 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Investigate the Initial Stages of Enamel Erosion in Vivo
- Lead sponsor
- GlaxoSmithKline
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2015
- Completion date
- November 6, 2015
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.